Fund 1 Investments LLC Boosts Stock Holdings in Indivior PLC (NASDAQ:INDV)

Fund 1 Investments LLC lifted its position in shares of Indivior PLC (NASDAQ:INDV - Free Report) by 28.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 709,086 shares of the company's stock after purchasing an additional 158,683 shares during the period. Indivior comprises 0.8% of Fund 1 Investments LLC's investment portfolio, making the stock its 24th largest holding. Fund 1 Investments LLC owned approximately 0.51% of Indivior worth $8,814,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in INDV. Mirae Asset Global Investments Co. Ltd. acquired a new position in Indivior in the 4th quarter valued at approximately $56,000. Stifel Financial Corp grew its position in shares of Indivior by 24.0% in the 4th quarter. Stifel Financial Corp now owns 12,675 shares of the company's stock valued at $158,000 after buying an additional 2,450 shares during the last quarter. Jane Street Group LLC acquired a new stake in shares of Indivior in the third quarter valued at about $180,000. Rathbones Group PLC raised its holdings in Indivior by 11.6% during the 4th quarter. Rathbones Group PLC now owns 14,284 shares of the company's stock worth $183,000 after purchasing an additional 1,483 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. bought a new position in Indivior during the fourth quarter worth $359,000. Institutional investors and hedge funds own 60.33% of the company's stock.

Indivior Stock Performance

Indivior stock traded up $0.26 during mid-day trading on Monday, reaching $11.34. The stock had a trading volume of 579,660 shares, compared to its average volume of 997,881. The firm has a market capitalization of $1.56 billion, a PE ratio of -32.40 and a beta of 0.98. Indivior PLC has a fifty-two week low of $7.33 and a fifty-two week high of $18.59. The stock's 50-day simple moving average is $9.97 and its 200-day simple moving average is $10.57.

Indivior (NASDAQ:INDV - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.22 by $0.19. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. The business had revenue of $266.00 million during the quarter, compared to analyst estimates of $240.13 million. On average, research analysts forecast that Indivior PLC will post 1.22 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently commented on INDV shares. Piper Sandler decreased their target price on Indivior from $16.00 to $13.00 and set an "overweight" rating for the company in a research note on Thursday, March 6th. RODMAN&RENSHAW upgraded shares of Indivior to a "strong-buy" rating in a research note on Tuesday, January 28th. Finally, Rodman & Renshaw assumed coverage on shares of Indivior in a research report on Tuesday, January 28th. They set a "buy" rating and a $16.00 target price on the stock.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.